<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Barry Yildirim | Activity</title>
	<link>https://www.catswannabecats.com/members/puffinloaf2/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/puffinloaf2/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Barry Yildirim.</description>
	<lastBuildDate>Mon, 22 Jun 2026 11:40:09 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">e2d88c9ccd6765880ec27001fa8a37c5</guid>
				<title>Barry Yildirim posted an update: The need for high-precision microprinting processes that are [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/25782/</link>
				<pubDate>Mon, 09 Jun 2025 11:47:01 -0400</pubDate>

									<content:encoded><![CDATA[<p>The need for high-precision microprinting processes that are controllable, scalable, and compatible with different materials persists throughout a range of biomedical fields. Electrospinning techniques offer scalability and compatibility with a wide arsenal of polymers, but typically lack precise three-dimensional (3D) control. We found that&hellip;<span class="activity-read-more" id="activity-read-more-25782"><a href="https://www.catswannabecats.com/activity/p/25782/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">43d198a73f6f952d2554bd0f43e86d33</guid>
				<title>Barry Yildirim posted an update: After a comprehensive geriatric assessment, frailty syndrome [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23977/</link>
				<pubDate>Sun, 08 Jun 2025 11:03:22 -0400</pubDate>

									<content:encoded><![CDATA[<p>After a comprehensive geriatric assessment, frailty syndrome was found in 57 patients (55.9%). In general, both scales showed solid performance, and differences between them in the sample were minimal. As the CGA showed a prevalence of frailty of 55.9%, a similar prevalence threshold for the ZFS (i.e., 64% at the threshold ≥3 could be assessed). T&hellip;<span class="activity-read-more" id="activity-read-more-23977"><a href="https://www.catswannabecats.com/activity/p/23977/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">78abe263345d9512339db716cf0f4457</guid>
				<title>Barry Yildirim posted an update: Two new species of the genus Dugesia (Platyhelminthes, [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20060/</link>
				<pubDate>Thu, 05 Jun 2025 11:10:46 -0400</pubDate>

									<content:encoded><![CDATA[<p>Two new species of the genus Dugesia (Platyhelminthes, Tricladida, Dugesiidae) from Hainan Island of China are described on the basis of morphological, karyological and molecular data. Dugesia semiglobosa Chen &amp; Dong, sp. nov. is mainly characterized by a hemispherical, asymmetrical penis papilla with ventrally displaced ejaculatory duct opening&hellip;<span class="activity-read-more" id="activity-read-more-20060"><a href="https://www.catswannabecats.com/activity/p/20060/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e6f8348c5ce83fe767a1456a556b1ebf</guid>
				<title>Barry Yildirim posted an update: Current methods to dynamically tune three-dimensional [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18168/</link>
				<pubDate>Tue, 03 Jun 2025 12:54:42 -0400</pubDate>

									<content:encoded><![CDATA[<p>Current methods to dynamically tune three-dimensional hydrogel mechanics require specific chemistries and substrates that make modest, slow, and often irreversible changes in their mechanical properties, exclude the use of protein-based scaffolds, or alter the hydrogel microstructure and pore size. Here, we rapidly and reversibly alter the&hellip;<span class="activity-read-more" id="activity-read-more-18168"><a href="https://www.catswannabecats.com/activity/p/18168/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a469f7f9d3185fb38ad16e2224a4d2f6</guid>
				<title>Barry Yildirim posted an update: Technological innovation and rapid reduction in sequencing [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/12825/</link>
				<pubDate>Sun, 01 Jun 2025 13:35:53 -0400</pubDate>

									<content:encoded><![CDATA[<p>Technological innovation and rapid reduction in sequencing costs have enabled the genomic profiling of hundreds of cancer-associated genes as a component of routine cancer care. Tumour genomic profiling can refine cancer subtype classification, identify which patients are most likely to benefit from systemic therapies and screen for germline&hellip;<span class="activity-read-more" id="activity-read-more-12825"><a href="https://www.catswannabecats.com/activity/p/12825/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0026af737f3efb55e6552aea96210fcd</guid>
				<title>Barry Yildirim posted an update: 011). Regarding patients with autologous serum as a previous [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/9565/</link>
				<pubDate>Sat, 31 May 2025 22:51:29 -0400</pubDate>

									<content:encoded><![CDATA[<p>011). Regarding patients with autologous serum as a previous treatment, no statistical differences were found in subjective or objective improvement. An overall success was achieved in 94.4% of the cases and no adverse events were found.</p>
<p> AMEED administration is a promising mean to treat OSD such as dry eye, persistent epithelial defect and&hellip;<span class="activity-read-more" id="activity-read-more-9565"><a href="https://www.catswannabecats.com/activity/p/9565/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">92d00538d9954b66228cf31ca0875686</guid>
				<title>Barry Yildirim became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/7241/</link>
				<pubDate>Sat, 31 May 2025 18:31:48 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>